These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

642 related items for PubMed ID: 25788222

  • 1. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E, Segura B, Obeso I, Cho SS, Houle S, Lang AE, Rusjan P, Sandor P, Strafella AP.
    Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.
    Graff-Guerrero A, Willeit M, Ginovart N, Mamo D, Mizrahi R, Rusjan P, Vitcu I, Seeman P, Wilson AA, Kapur S.
    Hum Brain Mapp; 2008 Apr; 29(4):400-10. PubMed ID: 17497628
    [Abstract] [Full Text] [Related]

  • 5. Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.
    Nakajima S, Caravaggio F, Boileau I, Chung JK, Plitman E, Gerretsen P, Wilson AA, Houle S, Mamo DC, Graff-Guerrero A.
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1812-8. PubMed ID: 26058690
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D, de Vries F, Cath D, Figee M, Vulink N, Veltman DJ, van der Doef TF, Boellaard R, Westenberg H, van Balkom A, Lammertsma AA, van Berckel BN.
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [Abstract] [Full Text] [Related]

  • 7. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N, Galineau L, Willeit M, Mizrahi R, Bloomfield PM, Seeman P, Houle S, Kapur S, Wilson AA.
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [Abstract] [Full Text] [Related]

  • 8. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects.
    Tolboom N, Berendse HW, Leysen JE, Yaqub M, van Berckel BN, Schuit RC, Ponsen MM, Bakker E, Hoetjes NJ, Windhorst AD, Carlsson ML, Lammertsma AA, Carlsson A.
    Neuropsychopharmacology; 2015 Jan; 40(2):472-9. PubMed ID: 25248987
    [Abstract] [Full Text] [Related]

  • 9. Reward motivation in humans and its relationship to dopamine D2/3 receptor availability: A pilot study with dual [11C]-raclopride and [11C]-(+)-PHNO imaging.
    Caravaggio F, Fervaha G, Browne CJ, Gerretsen P, Remington G, Graff-Guerrero A.
    J Psychopharmacol; 2018 Mar; 32(3):357-366. PubMed ID: 29442593
    [Abstract] [Full Text] [Related]

  • 10. The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.
    Graff-Guerrero A, Mamo D, Shammi CM, Mizrahi R, Marcon H, Barsoum P, Rusjan P, Houle S, Wilson AA, Kapur S.
    Arch Gen Psychiatry; 2009 Jun; 66(6):606-15. PubMed ID: 19487625
    [Abstract] [Full Text] [Related]

  • 11. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R, Slifstein M, Guillin O, Hwang Y, Hwang DR, Scher E, Reeder S, Rabiner E, Laruelle M.
    Synapse; 2006 Dec 01; 60(7):485-95. PubMed ID: 16952157
    [Abstract] [Full Text] [Related]

  • 12. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K, Johansson JJ, Tuokkola T, Någren K, Rinne JO.
    Neuroimage; 2013 Nov 15; 82():252-9. PubMed ID: 23727314
    [Abstract] [Full Text] [Related]

  • 13. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
    Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M.
    Addiction; 2013 May 15; 108(5):953-63. PubMed ID: 23167711
    [Abstract] [Full Text] [Related]

  • 14. Regional and source-based patterns of [11C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D2 and D3 receptor availability in cocaine-use disorder.
    Worhunsky PD, Matuskey D, Gallezot JD, Gaiser EC, Nabulsi N, Angarita GA, Calhoun VD, Malison RT, Potenza MN, Carson RE.
    Neuroimage; 2017 Mar 01; 148():343-351. PubMed ID: 28110088
    [Abstract] [Full Text] [Related]

  • 15. A Preliminary Investigation of the Effect of Acute Alcohol on Dopamine Transmission as Assessed by [11 C]-(+)-PHNO.
    Thiruchselvam T, Wilson AA, Boileau I, Le Foll B.
    Alcohol Clin Exp Res; 2017 Jun 01; 41(6):1112-1119. PubMed ID: 28421623
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
    Kiss B, Horti F, Bobok A.
    Synapse; 2011 Jun 01; 65(6):467-78. PubMed ID: 20936685
    [Abstract] [Full Text] [Related]

  • 17. Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.
    Shotbolt P, Tziortzi AC, Searle GE, Colasanti A, van der Aart J, Abanades S, Plisson C, Miller SR, Huiban M, Beaver JD, Gunn RN, Laruelle M, Rabiner EA.
    J Cereb Blood Flow Metab; 2012 Jan 01; 32(1):127-36. PubMed ID: 21878947
    [Abstract] [Full Text] [Related]

  • 18. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
    Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I.
    Mov Disord; 2015 Feb 01; 30(2):160-6. PubMed ID: 25641350
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2/3 Receptor Availabilities in Striatal and Extrastriatal Regions of the Adult Human Brain: Comparison of Four Methods of Analysis.
    Khodaii J, Nomura Y, Chang NHS, Wong DF, Møller A, Gjedde A.
    Neurochem Res; 2023 May 01; 48(5):1517-1530. PubMed ID: 36525123
    [Abstract] [Full Text] [Related]

  • 20. A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO.
    Matuskey D, Gaiser EC, Gallezot JD, Angarita GA, Pittman B, Nabulsi N, Ropchan J, MaCleod P, Cosgrove KP, Ding YS, Potenza MN, Carson RE, Malison RT.
    Drug Alcohol Depend; 2015 Sep 01; 154():167-73. PubMed ID: 26164205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.